sch 42495 has been researched along with natriuretic peptide, brain in 2 studies
Studies (sch 42495) | Trials (sch 42495) | Recent Studies (post-2010) (sch 42495) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
---|---|---|---|---|---|
18 | 5 | 0 | 16,317 | 1,867 | 8,887 |
Protein | Taxonomy | sch 42495 (IC50) | natriuretic peptide, brain (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crozier, IG; Espiner, EA; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
Espiner, EA; Lainchbury, JG; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
2 trial(s) available for sch 42495 and natriuretic peptide, brain
Article | Year |
---|---|
Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Humans; Hypertension; Indans; Male; Methionine; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Posture; Propionates; Time Factors | 1993 |
Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cyclic GMP; Drug Synergism; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Protease Inhibitors; Renin; Ventricular Dysfunction, Left | 1999 |